Ipamorelin CAS NO.170851-70-4

Ipamorelin Basic information
Product Name:    Ipamorelin
Synonyms:    IpoMarelin;IpaMorelin Acetate;Aib-His-D-2-Nal-D-Phe-Lys-NH2;IPAMORELIN(1MG);IPAMORELIN(5MG);2-Methylalanyl-L-histidyl-3-(2-naphthyl)-D-alanyl-D-phenylalanyl-L-lysinamide;L-Lysinamide,2-methylalanyl-L-histidyl-3-(2-naphthalenyl)-D-alanyl-D-phenylalanyl-;NNC-26-0161
CAS:    170851-70-4
MF:    C38H49N9O5
MW:    711.85
EINECS:    227-005-2
Product Categories:    Peptides;170851-70-4
Mol File:    170851-70-4.mol

pamorelin Chemical Properties
Melting point     144-147°C
Boiling point     1185.5±65.0 °C(Predicted)
density     1.263±0.06 g/cm3(Predicted)
storage temp.     -20°C Freezer
solubility     Acetonitrile (Slightly, Heated), Methanol (Very Slightly), Water (Slightly)
pka    13.04±0.46(Predicted)
form     Solid
color     White to Off-White
InChIKey    NEHWBYHLYZGBNO-BVEPWEIPSA-N
SMILES    C(N)(=O)[C@H](CCCCN)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](CC1=CC=C2C(=C1)C=CC=C2)NC(=O)[C@H](CC1N=CNC=1)NC(=O)[C@](C)(C)N

Ipamorelin Usage And Synthesis
Description    Ipamorelin (INN) (developmental code name NNC 26-0161) is a peptide selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS) and a growth hormone secretagogue.It is a pentapeptide with the amino acid sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2 that was derived from GHRP-1.
Uses    Ipamorelin was originally developed by Novo Nordisk, and was investigated in phase II clinical trials by Helsinn Therapeutics for the treatment of postoperative ileus, but was discontinued due to lack of efficacy.Ipamorelin has been used by athletes as a performance enhancing drug.
Uses    Ipamorelin is a metabolite of growth hormone releasing peptides (GHRPs). Ipamorelin is a pentapeptide with strong growth hormone releasing potency that evokes insulin release from pancrease of normal and diabetic rats.
benefits    Ipamorelin has a wide range of benefits for the human body such as: reduced body fat, increased collagen production, increased lean muscle mass, improved sleep, increased cell repair and regeneration, elevated IGF-1, increased bone mineral content, counteracted glucocorticoid catabolism, decreased appetite stimulation compared to GHRP-6, decreased release of cortisol, prolactin and aldosterone. Decreased release of cortisol, prolactin and aldosterone.
Side effects    Ipamorelin is generally considered safe and well tolerated, with common side effects including dizziness, headache, nausea, diarrhoea and flushing. Allergic or serious adverse reactions are rare.